Sex-determining Region Y-related (SRY) High-mobility Group Box 4 (SOX4) Immunoexpression in Colorectal Cancer as an Unappreciated Parameter for More Individual Approach in Cancer Disease – A Preliminary Study

Gąsior, Katarzyna Joanna; Hincz, Aleksandra; Cichoń, Marta Jadwiga; Kapszewicz, Paweł; Sałacińska-Łoś, Elżbieta; Orzechowska, Magdalena; Taran, Katarzyna

doi:10.36145/jhsm2021.14

References

1. Araghi M, Soerjomataram I, Jenkins M, Brierley J et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 2019; 144(12): 2992–3000.
Search in Google Scholar Back to article
2. Shin JK, Kim HC, Lee WY, Yun SH et al. High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score analysis. Ann Surg Treat Res 2019; 96(3): 107–115.
Search in Google Scholar Back to article
3. Labianca R, Beretta GD, Kildani B,Milesi L et al. Colon cancer. Crit Rev Oncol Hematol 2010; 74(2): 106–133.
Search in Google Scholar Back to article
4. Brenner H, Kloor M, Pox CP. Colorectal cancer. The Lancet 2014; 383(9927): 1490–1502.
Search in Google Scholar Back to article
5. Lopez G, Boggio F, Ferrero S, Fusco N, Del Gobbo A. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma. IJMS 2018; 19(10): 3014.
Search in Google Scholar Back to article
6. Nikolaou S, Qiu S, Fiorentino F, Rasheed S, Tekkis P, Kontovounisios C. Systematic review of blood diagnostic markers in colorectal cancer. Tech Coloproctol 2018; 22(7): 481–498.
Search in Google Scholar Back to article
7. Dong H, Hu J, Wang L, Qi M et al. SOX4 is activated by C-MYC in prostate cancer. Med Oncol 2019; 36(11): 92.
Search in Google Scholar Back to article
8. Moran JD, Kim HH, Li Z, Moreno CS. SOX4 regulates invasion of bladder cancer cells via repression of WNT5a. Int J Oncol 2019;55(2): 359–370.
Search in Google Scholar Back to article
9. Moreno CS. SOX4: The unappreciated oncogene. Seminars in Cancer Biology 2019; 67: 57–64.
Search in Google Scholar Back to article
10. Zhang J, Chai S, Ruan X. SOX4 Serves an Oncogenic Role in the Tumourigenesis of Human Breast Adenocarcinoma by Promoting Cell Proliferation, Migration and Inhibiting Apoptosis. Recent Pat Anticancer Drug Discov 2020; 15(1): 49-58.
Search in Google Scholar Back to article
11. Hanieh H, Ahmed EA, Vishnubalaji R, Alajez NM. SOX4: Epigenetic regulation and role in tumorigenesis. Semin Cancer Biol 2020; 67: 91–104.
Search in Google Scholar Back to article
12. SOX4 SRY-box transcription factor 4 [Homo sapiens (human)] – Gene –NC-BIn.d. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=6659 [citedJuly 6 2021].
Search in Google Scholar Back to article
13. Wang B, Li Y, Tan F, Xiao Z. Increased expression of SOX4 is associated with colorectal cancer progression. Tumour Biol 2016; 37(7): 9131–9137.
Search in Google Scholar Back to article
14. Vervoort SJ, van Boxtel R, Coffer PJ. The role of SRY – related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Oncogene 2013; 32(29): 3397–3409.
Search in Google Scholar Back to article
15. Liu Y, Zeng S, Jiang X, Lai D, Su Z. SOX4 inducestumourinvasion by targeting EMT-related pathway in prostate cancer. Tumour Biol 2017; 39(5): 1010428317694539.
Search in Google Scholar Back to article
16. Wang L, Zhang J, Yang X, Chang YWY et al. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro. Prostate Cancer Prostatic Dis 2013; 16(4): 301–307.
Search in Google Scholar Back to article
17. Tsai CN, Yu SC, Lee CW et al. SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo. Oncogene 2020; 39(24): 4695–4710.
Search in Google Scholar Back to article
18. Lin C-M, Fang C-L, Hseu Y-C, Chen C-L et al. Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer. PLoS One 2013; 8: e67128.
Search in Google Scholar Back to article
19. MouT-Y, Zhang R-R, Wang Y-N. MiRNA –212 acts as atumour–suppressor in colorectal carcinoma through targeting SOX4. Eur Rev Med Pharmacol Sci 2019; 23(24): 10751–10760.
Search in Google Scholar Back to article
20. Bao Z-Q, Zhang C-C, Xiao Y-Z, Zhou J-S, Tao Y-S, Chai D-M. Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma. J Huazhong Univ Sci Technolog Med Sci 2016; 36(2): 193-199.
Search in Google Scholar Back to article
21. Jin M, Frankel WL. Lymph Node Metastasis in Colorectal Cancer. Surgical Oncology Clinics of North America 2018; 27(2): 401–412.
Search in Google Scholar Back to article
22. Ruan H, Yang H, Wei H, Xiao W et al. Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition. Int J Oncol 2017; 51(1): 336–346.
Search in Google Scholar Back to article
23. Zhang J, Xiao C, Feng Z, Gong Y et al. SOX4 promotes the growth and metastasis of breast cancer. Cancer Cell Int 2020; 20: 468.
Search in Google Scholar Back to article
24. Yuan X, Wang S, Liu M, Lu Z et al. Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients. Biomed Res Int 2017; 6894675.
Search in Google Scholar Back to article
25. Callender GG, McMasters KM. What does ulceration of a melanoma mean for prognosis? Adv Surg 2011; 45: 225–236.
Search in Google Scholar Back to article
26. Micu BV, Vesa ŞC, Pop TR, Micu CM. Evaluation of prognostic factors for 5 year – survival after surgery for colorectal cancer. Ann Ital Chir 2020; 91: 41–48.
Search in Google Scholar Back to article
27. Poornakala S, Prema NS. A study of morphological prognostic factors in colorectal cancer and survival analysis. Indian J Pathol Microbiol 2019; 62(1): 36–42.
Search in Google Scholar Back to article

Sex-determining Region Y-related (SRY) High-mobility Group Box 4 (SOX4) Immunoexpression in Colorectal Cancer as an Unappreciated Parameter for More Individual Approach in Cancer Disease – A Preliminary Study

References

Paradigm

My account